.png){kind=icon}
返回
Devolution and drugs: the case for Welsh autonomy
.png){kind=icon}
PRE
AI
DOI：10.1332/0305573022501638.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
The regulation of drug prices is an excellent example of the type of tensions that are emerging in the UK's new system of multi-level governance. Both the benefits and regulatory burden of the Pharmaceutical Price Regulation Scheme (PPRS) are regionally concentrated. However, those regional concentrations are not coterminous. The PPRS as an industrial policy supports jobs primarily in the south east and east of England. However, Wales (along with Scotland and Northern Ireland) bears a relatively greater share of the regulatory burden of the PPRS by virtue of prescribing more medicines. The potential for Welsh autonomy in this area is considered in terms of economic, administrative and political constraints.
Keyword:
pharmaceutical policy
devolution
multi-level governance
parallel importing
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
